Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
iShares Expanded Tech-Software Sector ETF
IGV
$14.4B
| $7.52M | 0.01% |
139,500
+76,975
| +123% | +$4.52M |
|
352
DigitalOcean
DOCN
$14.7B
| $7.45M | 0.01% |
+180,086
| New | +$8.03M |
|
353
Vertex Pharmaceuticals
VRTX
$123B
| $7.4M | 0.01% |
26,253
+1,669
| +7% | +$447K |
|
354
FormFactor
FORM
$8.99B
| $7.38M | 0.01% |
190,532
-5,144
| -3% | -$198K |
|
|
B
355
DELISTED
Barnes Group Inc.
B
| $7.22M | 0.01% |
232,000
| – | – |
|
356
Atlantic Union Bankshares
AUB
$6.13B
| $7.09M | 0.01% |
209,000
| – | – |
|
357
First Interstate BancSystem
FIBK
$3.71B
| $7M | 0.01% |
183,560
+552
| +0.3% | +$19.7K |
|
358
United Rentals
URI
$72.6B
| $6.91M | ﹤0.01% |
28,428
-921
| -3% | -$271K |
|
|
MDC
359
DELISTED
M.D.C. Holdings, Inc.
MDC
| $6.87M | ﹤0.01% |
212,658
+36,037
| +20% | +$1.29M |
|
360
Neurocrine Biosciences
NBIX
$16.5B
| $6.87M | ﹤0.01% |
70,478
-4,178
| -6% | -$386K |
|
361
Snap-on
SNA
$21.7B
| $6.82M | ﹤0.01% |
34,586
-10,453
| -23% | -$2.23M |
|
362
Eversource Energy
ES
$27.2B
| $6.77M | ﹤0.01% |
80,198
-18,318
| -19% | -$1.63M |
|
363
CVS Health
CVS
$128B
| $6.69M | ﹤0.01% |
72,196
+4,416
| +7% | +$431K |
|
364
VanEck Semiconductor ETF
SMH
$72.5B
| $6.68M | ﹤0.01% |
65,602
+35,346
| +117% | +$4.1M |
|
365
Tetra Tech
TTEK
$8.78B
| $6.68M | ﹤0.01% |
244,575
+36,320
| +17% | +$996K |
|
366
Morningstar
MORN
$7.43B
| $6.67M | ﹤0.01% |
27,565
+6,753
| +32% | +$1.7M |
|
|
PCH
367
DELISTED
PotlatchDeltic
PCH
| $6.66M | ﹤0.01% |
150,710
+28,739
| +24% | +$1.48M |
|
368
Globe Life
GL
$14.2B
| $6.6M | ﹤0.01% |
67,752
+4,002
| +6% | +$392K |
|
369
Vanguard Total World Stock ETF
VT
$79.4B
| $6.48M | ﹤0.01% |
75,945
+13,462
| +22% | +$1.24M |
|
370
Associated Banc-Corp
ASB
$5.95B
| $6.45M | ﹤0.01% |
353,123
+123
| +0% | +$2.49K |
|
371
Acuity Brands
AYI
$10.7B
| $6.43M | ﹤0.01% |
41,744
+9,066
| +28% | +$1.54M |
|
372
Cooper Companies
COO
$14.5B
| $6.28M | ﹤0.01% |
80,236
-20,904
| -21% | -$1.85M |
|
373
ICU Medical
ICUI
$4.18B
| $6.25M | ﹤0.01% |
38,000
| – | – |
|
374
Weyerhaeuser
WY
$18.6B
| $6.12M | ﹤0.01% |
184,828
-43,035
| -19% | -$1.64M |
|
375
Southern Company
SO
$107B
| $6.11M | ﹤0.01% |
85,609
-80,850
| -49% | -$5.94M |
|
Similar funds
Fisher Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Fisher Asset Management held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fisher Asset Management's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Fisher Asset Management's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Fisher Asset Management added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Fisher Asset Management's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Fisher Asset Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Fisher Asset Management's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Fisher Asset Management opened 110 new positions and closed 131 in Q2 2022.
- Fisher Asset Management's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.